Capital City Trust Co. FL Has $1.84 Million Stake in Aflac Incorporated (NYSE:AFL)

Capital City Trust Co. FL trimmed its position in shares of Aflac Incorporated (NYSE:AFL) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,800 shares of the financial services provider’s stock after selling 320 shares during the period. Capital City Trust Co. FL’s holdings in Aflac were worth $1,841,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Darwin Wealth Management LLC acquired a new position in Aflac during the third quarter worth $34,000. Raelipskie Partnership bought a new position in Aflac during the third quarter worth $38,000. Covestor Ltd boosted its position in Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 107 shares during the period. Kennebec Savings Bank bought a new position in Aflac during the third quarter worth $45,000. Finally, Catalyst Capital Advisors LLC bought a new position in Aflac during the third quarter worth $51,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.90% of the company’s stock.

Aflac Stock Down 2.1 %

Shares of NYSE AFL opened at $102.04 on Friday. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The company has a market cap of $56.69 billion, a price-to-earnings ratio of 10.63, a PEG ratio of 3.31 and a beta of 0.99. Aflac Incorporated has a 12 month low of $78.62 and a 12 month high of $115.50. The stock has a 50-day moving average price of $104.11 and a two-hundred day moving average price of $107.29.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be paid a dividend of $0.58 per share. This is an increase from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date is Wednesday, February 19th. This represents a $2.32 annualized dividend and a yield of 2.27%. Aflac’s payout ratio is presently 24.17%.

Analysts Set New Price Targets

AFL has been the subject of a number of research analyst reports. BMO Capital Markets initiated coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective for the company. Keefe, Bruyette & Woods reduced their price objective on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Barclays reduced their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, February 7th. JPMorgan Chase & Co. lifted their price objective on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 7th. Finally, StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $102.86.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.